Humedix Co., Ltd. (KOSDAQ:200670)

Market Cap	448.93B
Revenue (ttm)	110.99B
Net Income (ttm)	9.06B
Shares Out	10.32M
EPS (ttm)	963.99
PE Ratio	45.13
Forward PE	10.07
Dividend	660.00 (1.51%)
Ex-Dividend Date	Nov 24, 2025

Volume	183,796
Average Volume	94,779
Open	43,550
Previous Close	43,500
Day's Range	41,950 - 43,600
52-Week Range	31,600 - 77,200
Beta	0.39
RSI	30.43
Earnings Date	Feb 11, 2026

About Humedix

Humedix Co., Ltd. engages in the manufacture and sale of various pharmaceutical products in South Korea. The company offers prescription medicines, active pharmaceutical ingredients, medical devices, cosmetic, and health functional food products. It is also involved in manufacture and distribution of anticancer drugs. The company was formerly known as HVLS Co., Ltd. and changed its name to Humedix Co., Ltd. in 2010. Humedix Co., Ltd. was founded in 2002 and is headquartered in Seongnam-si, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2002
• Employees: 248
• Stock Exchange: KOSDAQ
• Ticker Symbol: 200670

Financial Performance

In 2021, Humedix's revenue was 110.99 billion, an increase of 12.70% compared to the previous year's 98.48 billion. Earnings were 9.06 billion, a decrease of -39.91%.